Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Hector Gutierrez
Professor
Close
E-mail
pulmon@uab.edu
Links
Provider Directory
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Hector Gutierrez
Professor
Positions
Senior Scientist (C)
,
Cystic Fibrosis Research Center
,
School of Medicine
Scientist (C)
,
Center for Outcomes and Effectiveness Research and Education (COERE)
,
General Clinical Research Center
Senior Scientist (C)
,
Minority Health & Research Center
,
General Clinical Research Center
Professor (P)
,
Pediatric - Pulmonary & Sleep Medicine
,
Pediatrics
Acting Division Director
,
Pediatric - Pulmonary & Sleep Medicine
,
Pediatrics
Division Director
,
Pediatric - Pulmonary & Sleep Medicine
,
Pediatrics
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2022
Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis
.
Journal of Cystic Fibrosis
. 21:e8-e10.
2022
2021
A mobile health platform for self-management of pediatric cystic fibrosis: Qualitative study of adaptation to stakeholder needs and integration in clinical settings
.
JMIR Formative Research
. 5.
2021
2021
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study
.
Journal of Cystic Fibrosis
. 20:25-30.
2021
2020
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
.
Journal of Cystic Fibrosis
. 19:868-871.
2020
2020
Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis
.
Journal of Cystic Fibrosis
. 19:783-790.
2020
2020
Tobacco smoke exposure in pediatric cystic fibrosis: A qualitative study of clinician and caregiver perspectives on smoking cessation
.
Pediatric Pulmonology
. 55:2330-2340.
2020
2020
Newborn Screening for CF across the Globe-Where Is It Worthwhile?
.
International Journal of Neonatal Screening
. 6.
2020
2020
The future of cystic fibrosis care: a global perspective
2020
2016
Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening
.
Pediatric pulmonology. Supplement
. 51:1168-1176.
2016
2015
Adherence to airway clearance therapy in pediatric cystic fibrosis: Socioeconomic factors and respiratory outcomes
.
Pediatric pulmonology. Supplement
. 50:1244-1252.
2015
2014
ESCF care guidelines beyond Europe
.
Journal of Cystic Fibrosis
. 13:359-360.
2014
2014
Spiritual coping predicts 5-year health outcomes in adolescents with cystic fibrosis
.
Journal of Cystic Fibrosis
. 13:593-600.
2014
2014
Sustained improvement in nutritional outcomes at two paediatric cystic fibrosis centres after quality improvement collaboratives
.
BMJ Quality and Safety
. 23.
2014
2011
Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor.
.
Annals of Pharmacotherapy
. 45.
2011
2011
Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3a4 inhibitor
.
Annals of Pharmacotherapy
. 45.
2011
2010
Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational Cohort
.
Pediatric pulmonology. Supplement
. 45:934-944.
2010
2010
Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax
.
American Journal of Respiratory and Critical Care Medicine
. 182:298-306.
2010
2010
Improving the quality of care for patients with cystic fibrosis
.
Current Opinion in Pediatrics
. 22:296-301.
2010
2009
Cystic fibrosis care in Chile
.
Current Opinion in Pulmonary Medicine
. 15:632-637.
2009
2008
Creating a culture of improvement: experience of a pediatric cystic fibrosis center.
.
Journal of Nursing Care Quality
. 23:115-120.
2008
2008
Genetic and reproductive knowledge among adolescents and adults with cystic fibrosis
.
Chest
. 133:1533.
2008
1996
Nitric oxide regulation of superoxide-dependent lung injury: Oxidant- protective actions of endogenously produced and exogenously administered nitric oxide
.
Free Radical Biology and Medicine
. 21:43-52.
1996
1995
Oxygen Radical-Nitric Oxide Reactions in Vascular Diseases
1995
1995
Pulmonary alveolar epithelial inducible NO synthase gene expression: Regulation by inflammatory mediators
.
American Journal of Physiology
. 268.
1995
1993
Mycoplasmal infections. Epidemiology, immunology, diagnostic techniques, and therapeutic strategies
.
Immunology and Allergy Clinics of North America
. 13:43-57.
1993
Research
Principal Investigator On
A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System
awarded by
CHILDREN'S HOSPITAL & REGIONAL MEDICAL CENTER
A Multi-Center Study of a New Method of Sweat Testing: The CF Quantum Sweat Test
awarded by
University of Wisconsin-Madison
CF Center in Chile, Pilot and Feasibility Program
awarded by
Cystic Fibrosis Foundation ^
CF Learning Network: Implementation Phase
awarded by
CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI)
Cystic Fibrosis Newborn Screening
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening for Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening for Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening for Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening for Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening for Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening for Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening for Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening for Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening for Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening of Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening of Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening of Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Screening of Newborn Infants
awarded by
ALABAMA DEPARTMENT OF PUBLIC HEALTH
Cystic Fibrosis Training Network: Latin America
awarded by
Cystic Fibrosis Foundation ^
Developing Innovative GastroEnterology Specialty Training (DIGEST) Program - 2022
awarded by
Cystic Fibrosis Foundation ^
Early Recognition and Intervention for Acute Pulmonary Exacerbation in CF
awarded by
Cystic Fibrosis Foundation ^
I C.A.R.E. - I Change Adherence and Raise Expectations
awarded by
University of Miami
IMTI: International Mentoring Training Initiative
awarded by
Cystic Fibrosis Foundation ^
Implementation of the Depression and Anxiety Guideline: Award for a Mental Health Coordinator
awarded by
Cystic Fibrosis Foundation ^
Learning Network: Implementation Phase
awarded by
CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI)
Optimization of the Alabama CF Newborn Screening Program
awarded by
Cystic Fibrosis Foundation ^
Pediatric Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
The EPIC Observational Study: Longitudinal Assessment of Risk Factors for and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children with CF
awarded by
CHILDREN'S HOSPITAL & REGIONAL MEDICAL CENTER
The EPIC Observational Study: Longitudinal Assessment of Risk Factors for and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children with CF
awarded by
CHILDREN'S HOSPITAL & REGIONAL MEDICAL CENTER
The Effect of Formula Fortified with Docosahexaenoic Acid (DHA) on Infants with Cystic Fibrosis
awarded by
UNIVERSITY OF MASSACHUSETTS (WORCESTER)
Transformative Integrated Model for Continuous CF Care
awarded by
Cystic Fibrosis Foundation ^
UAB CF Research and Translation Core Center - Pilot Supplement
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
Investigator On
Childhood Pulmonary and Related Outcomes after Perinatal Exposure to Adjunctive Azithromycin Prophylaxis For Cesarean Delivery (C/SOAP Follow-up Study)
awarded by
National Institute of Child Health and Human Development/NIH/DHHS
Development of Standardized Measures of Barriers to Treatment Adherence: Field Testing and Psychometric Validation
awarded by
CHILDREN'S HOSPITAL (BOSTON)
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients with Cystic Fibrosis
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Prevalence and Significance of Staphylococcus Aureus Small–Colony Variants
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
Gilead Sciences ^
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
GlaxoSmithKline
Success with Therapies Research Consortium
awarded by
Cystic Fibrosis Foundation ^
Technology-Enabled Patient Support System for Self-Management of Pediatric Cystic Fibrosis
awarded by
KAUL PEDIATRIC RESEARCH INSTITUTE
UAB CF Research and Translation Core Center
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
Background
Education And Training
Pontifical Catholic University of Chile Pediatrics, Residency
University of Maryland Medical System Pediatrics, Residency
University of Alabama at Birmingham Pediatrics, Postdoctoral Fellowship
Doctor of Medicine,
1983
Contact
Full Name
Hector
Gutierrez